Nanobiotix at the HC Wainwright Global Investment Conference
- Sep 11, 2025
- 1 min read

Nanobiotix, a French biotechnology company listed on Euronext and NASDAQ, will participate in the 27th annual HC Wainwright Global Investment Conference. The event will be held on September 9, 2025, in New York City. Nanobiotix representatives Laurent Levy and Bart van Rhijn will participate in a live discussion broadcast on the company's website.
Specializing in nanoparticle-based therapeutic approaches, Nanobiotix aims to expand treatment options for patients with cancer and other diseases. Presentations will be available to a wider audience after the event.














